Focused on creating novel oral antisense oligonucleotide therapies

Our Pipeline

Clinical and Pre-Clinical Programs

Civi new pipeline 6-23

Our Products

CiVi 030

CiVi 030 is an intravenous formulation of iloprost, a potent vasodilator and platelet inhibitor with anti-inflammatory and anti-fibrotic effects being developed for the treatment of severe frostbite.

CiVi 008

CiVi 008 is a third generation PCSK9 antisense molecule being developed as an oral treatment for hypercholesterolemia and the prevention of atherosclerotic cardiovascular disease.